Zalicus Phase 2 PHN and Convergene Phase 2 PHN both coming off in Q4.
Merck may have to move to be first to market.
Estimated Primary Completion Date: January 2014
Estimated Enrollment: 90
Sentiment: Strong Buy
Convergence started Phase II five months later than Z, Even if they had a lesser number of participants (90 against Z. 140) how come they completed Phase II at the same time?
3-pyridylcarbonyl-piperazinylsulfonyl vs. N-piperidinyl acetamide